WARMTH patients only received a median of three cycles because Lu-PSMA was no longer effective after that point.
The median of 5 cycles in LuPIN is a big plus for NOX66: the combination of NOX66 and Lu-PSMA worked for a longer time, which is good for patients; and Novartis would be able to charge their fees for additional cycles, which would be good for Novartis.
- Forums
- ASX - By Stock
- NOX
- Ann: New Independent Trial Data Supports Potential of Veyonda
Ann: New Independent Trial Data Supports Potential of Veyonda, page-18
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.6¢ |
Change
0.003(3.23%) |
Mkt cap ! $28.05M |
Open | High | Low | Value | Volume |
9.2¢ | 9.6¢ | 9.0¢ | $16.54K | 175.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 100000 | 9.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 29664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 100000 | 0.091 |
1 | 99321 | 0.090 |
1 | 100000 | 0.086 |
2 | 112345 | 0.081 |
2 | 112500 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 10000 | 1 |
0.105 | 82221 | 2 |
0.110 | 24430 | 3 |
0.115 | 81818 | 1 |
0.120 | 96624 | 2 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online